WHO's 2026 nutrition rules mean big changes for food companies. Learn why they must cut sugar, salt, and fat or face market loss.
Editorial Team
·
Is your CTV ad strategy costing you? Learn why proactive brand safety matters for long-term equity and what to do by 2026.
·
Pharma faces high costs. See 5 ways to improve drug development ROI, like using AI to cut early-phase costs by up to 30%, speeding new treatments.
·
Public opinion is split on CRISPR gene editing. Learn why costs exceed $1M and how regulations grapple with this powerful medicine.
·
Only 15% of critical medicines reach low-income nations, per WHO. Learn why global market access fails and what's next for life-saving treatments.
·
·
7 min read
CRISPR could cut livestock antibiotic use and carbon footprint. See how gene-edited animals may reshape food production by 2030.
·
·
6 min read
CRISPR investment hits $15B by 2030. See how NIH funding and VC are driving gene editing therapies, diagnostics, and future challenges.
·
·
9 min read
CTV programmatic ad spending hits $47.5B by 2027. Understand this market shift, why it matters for advertisers, and what's next for ad tech.
·
·
5 min read
CTV ad fraud costs billions. Learn how to protect your ad spend with multi-layered detection, vendor transparency, and strict verification protocols.
·
·
7 min read
CRISPR medicine could hit $15 billion by 2028. Understand its ethical investment challenges, market growth, and what to watch next.
·
·
8 min read
